Annual Current Liabilities
$18.95 M
+$3.22 M+20.47%
December 31, 2023
Summary
- As of February 28, 2025, FDMT annual total current liabilities is $18.95 million, with the most recent change of +$3.22 million (+20.47%) on December 31, 2023.
- During the last 3 years, FDMT annual current liabilities has risen by +$2.21 million (+13.18%).
- FDMT annual current liabilities is now at all-time high.
Performance
FDMT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$29.46 M
+$10.06 M+51.86%
September 30, 2024
Summary
- As of February 28, 2025, FDMT quarterly total current liabilities is $29.46 million, with the most recent change of +$10.06 million (+51.86%) on September 30, 2024.
- Over the past year, FDMT quarterly current liabilities has increased by +$11.30 million (+62.23%).
- FDMT quarterly current liabilities is now at all-time high.
Performance
FDMT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
FDMT Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.5% | +62.2% |
| 3 y3 years | +13.2% | +62.2% |
| 5 y5 years | +135.3% | +62.2% |
FDMT Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.5% | at high | +161.3% |
| 5 y | 5-year | at high | +46.3% | at high | +198.5% |
| alltime | all time | at high | +220.8% | at high | +265.8% |
4D Molecular Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $29.46 M(+51.9%) |
| Jun 2024 | - | $19.40 M(+18.3%) |
| Mar 2024 | - | $16.40 M(-13.4%) |
| Dec 2023 | $18.95 M(+20.5%) | $18.95 M(+4.3%) |
| Sep 2023 | - | $18.16 M(+32.1%) |
| Jun 2023 | - | $13.75 M(+21.9%) |
| Mar 2023 | - | $11.28 M(-28.3%) |
| Dec 2022 | $15.73 M | $15.73 M(+16.0%) |
| Sep 2022 | - | $13.56 M(-5.4%) |
| Jun 2022 | - | $14.33 M(+18.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $12.09 M(-26.0%) |
| Dec 2021 | $16.34 M(-2.4%) | $16.34 M(+43.7%) |
| Sep 2021 | - | $11.37 M(+15.2%) |
| Jun 2021 | - | $9.87 M(-29.1%) |
| Mar 2021 | - | $13.92 M(-16.9%) |
| Dec 2020 | $16.74 M(+29.2%) | $16.74 M(+17.3%) |
| Sep 2020 | - | $14.28 M(+10.2%) |
| Dec 2019 | $12.96 M(+60.9%) | $12.96 M(+50.6%) |
| Jun 2019 | - | $8.60 M(+6.8%) |
| Dec 2018 | $8.05 M(+36.3%) | $8.05 M |
| Dec 2017 | $5.91 M | - |
FAQ
- What is 4D Molecular Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual current liabilities year-on-year change?
- What is 4D Molecular Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly current liabilities year-on-year change?
What is 4D Molecular Therapeutics annual total current liabilities?
The current annual current liabilities of FDMT is $18.95 M
What is the all time high annual current liabilities for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual total current liabilities is $18.95 M
What is 4D Molecular Therapeutics annual current liabilities year-on-year change?
Over the past year, FDMT annual total current liabilities has changed by +$3.22 M (+20.47%)
What is 4D Molecular Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of FDMT is $29.46 M
What is the all time high quarterly current liabilities for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly total current liabilities is $29.46 M
What is 4D Molecular Therapeutics quarterly current liabilities year-on-year change?
Over the past year, FDMT quarterly total current liabilities has changed by +$11.30 M (+62.23%)